Nurse-Led Care Model Cuts Heart Failure Deaths by 22% in Major India Trial

A nurse-coordinated care model tested across 22 hospitals in India has cut the risk of death in heart failure patients by 22 percent over two years, according to results presented at the European Society of Cardiology Congress in Munich and published simultaneously in the journal Circulation on August 30, 2026.

The trial, known as TIME-HF, addresses one of the most persistent gaps in cardiology: patients are routinely under-treated with medications proven to extend their lives, especially outside wealthy countries.

Why the gap matters

Heart failure affects more than 64 million people worldwide, and a specific set of medications, known as guideline-directed medical therapy, has repeatedly been shown to reduce hospitalizations and deaths. Getting patients onto these drugs, and keeping them there, is one of the most effective things cardiology has to offer.

In practice, that rarely happens. Research published this year found that only 19 percent of heart failure patients in low- and middle-income countries were sent home from the hospital on all three major drug classes, compared with 41 percent in high-income countries. Six months later, the gap widens further, to 15 percent versus 37 percent. Even when patients are prescribed the drugs, they are often under-dosed, and the same research found women in low-income countries were about four times less likely than men in wealthy countries to be on any recommended therapy at all.

What the trial changed

TIME-HF enrolled 1,507 adults with reduced heart pumping function, average age 62, nearly a third of them women and more than half living in rural areas. Hospitals were randomly assigned to either usual care or a nurse-coordinated model, in which trained nurses worked alongside physicians, used a mobile health app to track symptoms and communicate with patients between visits, and delivered structured counseling on medications and lifestyle changes.

At two years, 37.3 percent of patients in the nurse-coordinated group were on full guideline-directed therapy, compared with 22.1 percent in the usual-care group. That is still short of ideal, but it represents a meaningfully larger share of patients receiving proven treatment than the low- and middle-income country baseline of 15 to 19 percent found elsewhere, in a population that was more rural and lower-resourced than many hospital-based studies.

The clinical payoff followed the same pattern. Patients in the nurse-coordinated group had an 84.0 percent probability of surviving without a hospitalization, compared with 79.4 percent in the usual-care group, and saw 22 percent fewer deaths overall over the two-year follow-up.

A model built for stretched health systems

Dr. Panniyammakal Jeemon of the Sree Chitra Tirunal Institute for Medical Sciences and Technology, who led the trial, said the approach "may offer a practical strategy to improve heart failure outcomes in routine care," adding that it could apply "not only [to] low- and middle-income countries but also to other settings."

That framing matters because the intervention was designed around constraints common to overstretched health systems: relatively few specialist physicians, patients traveling long distances for follow-up, and limited time for in-person counseling. Rather than requiring more doctors, the model shifts structured, ongoing care onto trained nurses supported by a mobile app, a structure that is easier to scale in places where cardiologists are scarce.

What comes next

Researchers have not yet detailed formal plans to expand the program beyond the 22 trial centers, but the size of the study, its rural and lower-income patient population, and its peer-reviewed publication in Circulation give health systems a concrete, tested model to consider adopting rather than a small pilot result. Questions that remain include how the approach performs outside India, how it holds up over longer follow-up periods, and what it costs to train and deploy nurses at scale.

For a field where the evidence-practice gap is often the biggest obstacle to saving lives, a trial showing that better-organized, nurse-led follow-up meaningfully narrows that gap is a rare piece of good news with a clear, replicable structure behind it.